Similar Search Results

The allocation of control rights in pharmaceutical alliances

Higgins, Matthew J. - In: The journal of corporate finance : contracting, … 13 (2007) 1, pp. 58-75

Persistent link: https://www.econbiz.de/10003460174

The outsourcing of R&D through acquisitions in the pharmaceutical industry

Higgins, Matthew J.; Rodriguez, Daniel - In: Journal of financial economics 80 (2006) 2, pp. 351-383

Persistent link: https://www.econbiz.de/10003324533

Productivity and the role of complementary assets in firms' demand for technology innovations

Ceccagnoli, Marco; Graham, Stuart J. H.; Higgins, Matthew J. - In: Industrial and corporate change 19 (2010) 3, pp. 839-869

Persistent link: https://www.econbiz.de/10008647604

The impact of declining research productivity in the pharmaceutical sector on corporate finance decisions

Higgins, Matthew J. - 2004

Persistent link: https://www.econbiz.de/10003551065

Corporate venture capital as a real option in the markets for technology

Ceccagnoli, Marco; Higgins, Matthew J.; Kang, Hyunsung D. - 2015

Persistent link: https://www.econbiz.de/10011332933

Assets with "warts" : how reliable is the market for technology?

Palermo, Vincenzo; Higgins, Matthew J.; Ceccagnoli, Marco - 2015

Persistent link: https://www.econbiz.de/10010530696

Behind the scenes : sources of complementarity in R&D

Ceccagnoli, Marco; Higgins, Matthew J.; Palermo, Vincenzo - 2013

Persistent link: https://www.econbiz.de/10009722826

The Role of Assets In Place : Loss of Market Exclusivity and Investment

Higgins, Matthew J. - 2020

We utilize a novel identification strategy to analyze the impact of assets in place on firms' decisions for future projects. We exploit the context in the pharmaceutical industry, where the loss of market exclusivity for a branded drug can be used to separate the impact of cash flows generated...

Persistent link: https://www.econbiz.de/10012481442

The role of assets in place : loss of market exclusivity and investment

Higgins, Matthew J.; Kronlund, Mathias J.; Park, Ji Min; … - 2020

Persistent link: https://www.econbiz.de/10012265375

Regulation and welfare : evidence from paragraph IV generic entry in the pharmaceutical industry

Branstetter, Lee; Chatterjee, Chirantan; Higgins, Matthew J. - In: The Rand journal of economics 47 (2016) 4, pp. 857-890

Persistent link: https://www.econbiz.de/10011665407